Charles Schwab’s Clene CLNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,285
Closed -$9.15K 3518
2024
Q2
$9.15K Hold
1,285
﹤0.01% 3617
2024
Q1
$10.9K Hold
1,285
﹤0.01% 3460
2023
Q4
$7.62K Hold
1,285
﹤0.01% 3533
2023
Q3
$12.7K Hold
1,285
﹤0.01% 3549
2023
Q2
$22.6K Hold
1,285
﹤0.01% 3545
2023
Q1
$29K Buy
+1,285
New +$33.3K ﹤0.01% 3453
2022
Q3
Sell
-4,837
Closed -$244K 3515
2022
Q2
$244K Sell
4,837
-3,378
-41% -$189K ﹤0.01% 3217
2022
Q1
$648K Buy
8,215
+1,561
+23% +$94.4K ﹤0.01% 3019
2021
Q4
$546K Sell
6,654
-487
-7% -$52.1K ﹤0.01% 3119
2021
Q3
$976K Sell
7,141
-229
-3% -$39.1K ﹤0.01% 2881
2021
Q2
$1.66M Buy
7,370
+2,553
+53% +$538K ﹤0.01% 2781
2021
Q1
$1.23M Buy
+4,817
New +$1.06M ﹤0.01% 2788

Other funds holding CLNN

Charles Schwab's CLNN Position: Q3 2024 in Review

Charles Schwab sold out of Clene (CLNN) in Q3 2024, closing a stake of 1,285 shares — an estimated $9.15K sold.

Charles Schwab first reported a position in CLNN in Q1 2021 and held it in 12 quarters. The position peaked at $1.66M in Q2 2021. 20 funds tracked by Wall St. Rank hold CLNN as of Q3 2024.

  • Charles Schwab reported no remaining Clene position as of Q3 2024 after selling out during the quarter.
  • Charles Schwab sold 1,285 Clene shares in Q3 2024, an estimated $9.15K.
  • Charles Schwab first reported a position in Clene in Q1 2021 and held it in 12 quarters.
  • Charles Schwab's Clene position peaked at $1.66M in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Clene as of Q3 2024.

Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.